Phase 1 Uterine Bleeding Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1
Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding
Abnormal Uterine Bleeding
ScinnoHub Pharmaceutical Co., Ltd.39 enrolled1 locationNCT07169214
Recruiting
Phase 1
Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy
AnalgesiaAbnormal Uterine BleedingParacervical Block
Icahn School of Medicine at Mount Sinai60 enrolled1 locationNCT06653400